News

Published on 21 Sep 2021 on Benzinga

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback,...

Article preview image

Here's a roundup of top developments in the biotech space over the last 24 hours:

(Biotech Stocks Hitting 52-week Highs Sept. 20)

Read the rest of the article
NASDAQ.LHDX price evolution
NYSE.RMED price evolution
NASDAQ.ADTX price evolution
NASDAQ.VRDN price evolution
NASDAQ.APLT price evolution
NASDAQ.CERE price evolution
NASDAQ.AFIB price evolution
NASDAQ.SGEN price evolution
NASDAQ.GMAB price evolution
NYSE.BSX price evolution
NASDAQ.INCY price evolution
ASX.MSB price evolution
NASDAQ.TXMD price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Incyte Corporation (NASDAQ:INCY) Yearly Results Just Came Out: Here's What Analysts Are Forecasting...

As you might know, Incyte Corporation (NASDAQ:INCY) recently reported its yearly numbers. Results...

Simply Wall St. via Yahoo Finance 15 Feb 2024
Incyte downgraded amid missed acquisition opportunity

On Wednesday, JMP Securities adjusted its stance on Incyte (NASDAQ: INCY ) Corporation...

Investing.com 14 Feb 2024
Earnings call: Incyte reports record $1 billion in Q4 with strong pipeline

Incyte Corporation (NASDAQ: INCY ) delivered a robust performance in the fourth quarter of 2023,...

Investing.com 13 Feb 2024
Incyte Corporation (NASDAQ:INCY) Q4 2023 Earnings Call Transcript

Incyte Corporation (NASDAQ:INCY) Q4 2023 Earnings Call Transcript February 13, 2024 Incyte Corpor...

Insider Monkey via Yahoo Finance 13 Feb 2024
Drug, Biotech Stocks' Q4 Earnings Due on Feb 13: BIIB, ZTS & INCY

The fourth-quarter earnings season for the drug and biotech sector is almost halfway through. Mos...

Zacks via Yahoo Finance 12 Feb 2024
Incyte (INCY) to Report Q4 Earnings: What's in the Cards?

Incyte Corporation INCY is scheduled to release fourth-quarter and full-year 2023 results on Feb ...

Zacks via Yahoo Finance 9 Feb 2024
Is Incyte Corporation's (NASDAQ:INCY) Recent Stock Performance Influenced By Its Fundamentals In Any...

Incyte (NASDAQ:INCY) has had a great run on the share market with its stock up by a significant 1...

Simply Wall St. via Yahoo Finance 23 Jan 2024
Investors in Incyte (NASDAQ:INCY) from three years ago are still down 34%, even after 4.4% gain this...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the re...

Simply Wall St. via Yahoo Finance 5 Nov 2023
Earnings call: Incyte reports double-digit revenue growth in Q3 2023, advances in clinical...

Earnings call: Incyte reports double-digit revenue growth in Q3 2023, advances in clinical...

Investing.com 1 Nov 2023
Incyte (INCY) Beats on Q3 Earnings, Misses Revenue Estimates

Incyte Corporation INCY reported third-quarter 2023 adjusted earnings of $1.10 per share, which b...

Zacks via Yahoo Finance 31 Oct 2023

Copyright Statfolio @ 2024

Social Accounts